New drug targets genetic driver in advanced cancers
Disease control
Not yet recruiting
This study is testing whether an experimental drug called lirafugratinib can help control advanced solid tumors that have a specific genetic change called FGFR2 fusion or rearrangement. The trial is for adults whose cancer has spread or cannot be surgically removed and who have a…
Phase: PHASE2 • Sponsor: Elevar Therapeutics • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC